Array Card News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Egis Pharmaceuticals PLC Announces Registration of the First Blood-based CE IVD Precision Medicine Tool for Therapy Selection in Rheumatoid Arthritis
Share Article
Egis Pharmaceuticals PLC (Egis) received the CE In Vitro Diagnostic (IVD) Medical Device Certificate of its PREDYSTIC® Infliximab RA Kit on December 21st, 2020.
BUDAPEST, Hungary (PRWEB)
March 16, 2021
The PREDYSTIC® Infliximab RA Kit is a first-in-class, CE IVD labelled, molecular biomarker diagnostic system, suitable for predicting infliximab responsiveness in rheumatoid arthritis patients, before the first biological treatment initiation. This novel tool supports the decision making of stakeholders including rheumatologists, patients, payors, and drug developers.
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder affecting around 1% of the worldwide population. Clinical therapeutic options are still limit ....

Brian Lockhart , Michelle Collins , Zsolt Holl , Aegis Pharmaceuticals , Servier Group , Business Development , Vitro Diagnostic Medical Device Regulation , Applied Biosystems , Gene Expression Taqman , Array Card , Thermo Fisher Scientific , Biological Business Development , Companion Diagnostics , Commercial Supply , Thermo Fisher , Active Pharmaceutical Ingredients , Finished Drug Products , Eastern Europe , Press Release , பிரையன் லாக்ஹார்ட் , மைக்கேல் கோலின்ஸ் , வணிக வளர்ச்சி , விட்ரோ கண்டறியும் மருத்துவ சாதனம் ஒழுங்குமுறை , பயன்படுத்தப்பட்டது உயிர் அமைப்புகள் , வரிசை அட்டை , தெர்மோ மீனவர் அறிவியல் ,